Best Tech Stocks To Buy For 2019

Akamai Technologies Inc. (NASDAQ: AKAM) shares dipped on Tuesday after the company announced updated guidance for the coming quarter and the full year in connection with its analyst day.

In most cases, if a company is expecting a rough quarter, it is better off to update guidance ahead of the results and get it over with rather than suffer later when the stakes could be higher.

Due to the strengthening of the dollar since the guidance was issued on April 30, revenue and earnings for the second quarter are expected to face a headwind of $3 million and $0.01, respectively. As a result, the company now anticipates its second quarter 2018 revenue range to be $658 million to $663 million and earnings per share (EPS) to be between $0.79 and $0.81.

Thomson Reuters consensus estimates call for $0.80 in EPS and $665.85 million in revenue for the quarter.

Looking ahead to the full year, Akamai now expects its 2018 revenue range to be $2.675 billion to $2,705 billion and EPS of $3.20 to $3.30. The increase to EPS guidance is due to expected improvement in the company’s operating margins. Previously the company anticipated revenue in the range of $2.69 billion to $2.72 billion and EPS in the range of $3.15 to $3.25.

Best Tech Stocks To Buy For 2019: Silicon Graphics International Corp(SGI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Superior Gold (CVE:SGI) will be releasing its earnings data before the market opens on Tuesday, August 21st. Analysts expect Superior Gold to post earnings of C$0.05 per share for the quarter.

Best Tech Stocks To Buy For 2019: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Brian Stoffel]

    Shareholders of Veeva Systems (NYSE:VEEV) have had a lot to cheer about recently. The company — which aims to provide a one-stop cloud solution for all the needs of pharmaceutical companies — has seen its stock almost quintuple since February 2016 on the back of consistently strong earnings reports.

  • [By Dan Caplinger]

    Friday saw a breakout session for the stock market, as major benchmarks like the S&P 500 and the Nasdaq Composite set record highs. For the broad-based S&P 500, the record was the first it had set since early this year, and for many investors, it served as confirmation that the bull market in stocks could continue as it approaches its 10th anniversary in early 2019. Several positive news items from individual companies also helped lead indexes higher. Netflix (NASDAQ:NFLX), Autodesk (NASDAQ:ADSK), and Veeva Systems (NYSE:VEEV) were among the best performers on the day. Here’s why they did so well.

  • [By Brian Stoffel]

    The two companies in today’s matchup share the same roots. Peter Gassner, founder and CEO of Veeva Systems (NYSE:VEEV), was an executive at Salesforce (NYSE:CRM) when he realized an opportunity: Drug companies had specific cloud needs that Salesforce couldn’t meet.

  • [By Motley Fool Staff]

    Matt Wallach is the co-founder and president of Veeva Systems (NYSE:VEEV), a cloud-based software company that found success catering to the life-sciences industry. But the company isn’t stopping there.

  • [By Motley Fool Staff]

    Veeva Systems (NYSE:VEEV) Q1 2018 Earnings Conference CallMay. 24, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Beth McKenna]

    Shares of Veeva Systems (NYSE:VEEV) rocketed 38% in August, according to data from S&P Global Market Intelligence. This brings the life sciences industry-focused, cloud-based software solutions provider’s year-to-date 2018 return to 82.7% through Wednesday, Sept. 5.

Best Tech Stocks To Buy For 2019: QuickLogic Corporation(QUIK)

Advisors’ Opinion:

  • [By Paul Ausick]

    QuickLogic Corp. (NASDAQ: QUIK) traded down about 33% Thursday and posted a new 52-week low of $1.05 after closing Wednesday at $1.56. The stock’s 52-week high is $2.22. Volume totaled around 4.8 million, about 30 times the daily average of around 180,000. The company priced a secondary offering of 13.5 million units including 0.4 of a warrant at $1.15 per unit.

  • [By Logan Wallace]

    QuickLogic (NASDAQ: QUIK) and SemiLEDs (NASDAQ:LEDS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on QuickLogic (QUIK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    QuickLogic Co. (NASDAQ:QUIK)’s share price reached a new 52-week low during trading on Friday . The stock traded as low as $0.98 and last traded at $0.97, with a volume of 294 shares. The stock had previously closed at $0.99.

Best Tech Stocks To Buy For 2019: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Jim Crumly]

    As for individual stocks, shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) fell despite the announcement of its first-ever drug approval, and those of Sysco (NYSE:SYY) rose on earnings.

  • [By Shane Hupp]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Although we are pleased with Alnylam’s broad and promising pipeline, we note that most candidates are in their early or mid stages of development. These candidates still have a long way to go before hitting the market. Currently, Alnylam depends heavily on Onpattro for growth. We also note that gaining approval for pipeline candidates has become more difficult now.  However,  In August, Alnylam got a significant boost with the approval of Onpattro (patisiran), a first-of-its-kind RNA interference (RNAi) therapeutic, both in the United States and in Europe, for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. This is the first approved candidate for the company and hence should drive revenues. Loss estimates have remained stable ahead of the Q3 earnings release.”

  • [By Max Byerly]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) last issued its quarterly earnings results on Thursday, May 3rd. The biopharmaceutical company reported ($1.41) EPS for the quarter, topping analysts’ consensus estimates of ($1.47) by $0.06. The business had revenue of $21.90 million during the quarter, compared to analysts’ expectations of $35.23 million. Alnylam Pharmaceuticals had a negative return on equity of 36.81% and a negative net margin of 565.20%. The business’s quarterly revenue was up 15.3% on a year-over-year basis. During the same quarter in the prior year, the business posted ($1.25) earnings per share. equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post -6.7 earnings per share for the current fiscal year.

  • [By Cory Renauer]

    Anyone who likes a good underdog story will want to keep their eye on Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and GW Pharmaceuticals PLC (NASDAQ:GWPH) through this year and next as they launch their first products in the U.S. Smaller biotechs have a terrible track record when it comes to launching new drugs on their own, but most analysts expect these companies to buck the trend and propel their recently approved drugs to blockbuster status within a few years.

  • [By Cory Renauer]

    If approved, Tegsedi will run directly into competition with Alnylam’s (NASDAQ:ALNY) recently approved treatment for the limited population of ATTR patients, Onpattro. Inotersen and Onpattro haven’t been tested in a head-to-head study, but most analysts expect Alnylam’s drug to gain a much larger share of the limited space than Akcea’s.

  • [By Ethan Ryder]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday.

Best Tech Stocks To Buy For 2019: MINDBODY, Inc.(MB)

Advisors’ Opinion:

  • [By Brian Withers]

    Running a small business is tough. Competing against larger competitors with deep pockets is a constant challenge on a shoestring budget. Four companies making it easier for small businesses thrive are Q2 Holdings (NYSE:QTWO), Shopify (NYSE:SHOP), Square (NYSE:SQ) and Mindbody (NASDAQ:MB). These fast-growing tech companies provide cloud-based platforms that handle key functions for small businesses at a low cost, and their shareholders are enjoying the results. 

  • [By Joe Tenebruso]

    Mindbody (NASDAQ:MB) is the leading cloud-based software platform for the global fitness, wellness, and beauty services industry. Mindbody’s software helps these often small- and midsize-businesses run their operations more efficiently and profitably, with tools like online appointment setting, staff management, marketing, analytics, and payments, among others. Moreover, with plans starting at $125 per month, Mindbody offers a scalable platform that can grow along with its customers. The company says that its offerings are therefore appropriate for local businesses all the way up to national chains and large enterprises. 

  • [By Stephan Byrd]

    MINDBODY (NASDAQ:MB) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday.

  • [By Max Byerly]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:

    Get MINDBODY alerts:

    Target Price Focus on Shares of MINDBODY, Inc. (NASDAQ:MB) (vassarnews.com) Analytical Report on MINDBODY inc (NASDAQ:MB) (newburghpress.com) 200 days simple moving average (SMA200) Indicator under Consideration MINDBODY, Inc. (NASDAQ:MB), Navigant … (stocksnewspoint.com) Stock Current Update -MINDBODY, Inc. (MB) (topdesertsafari.com) Becoming More Capital Intensive? MINDBODY, Inc. (MB), Adamis Pharmaceuticals Corporation (ADMP) (nmsunews.com)

    MB has been the topic of a number of analyst reports. BidaskClub cut shares of MINDBODY from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 1st. KeyCorp reiterated a “buy” rating and set a $47.00 price objective on shares of MINDBODY in a research report on Wednesday, August 1st. DA Davidson reiterated a “buy” rating on shares of MINDBODY in a research report on Wednesday, May 9th. TheStreet upgraded shares of MINDBODY from a “d+” rating to a “c” rating in a research report on Monday, June 18th. Finally, Morgan Stanley boosted their price objective on shares of MINDBODY from $39.00 to $42.00 and gave the company an “equal weight” rating in a research report on Wednesday, May 9th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $37.77.

  • [By Shane Hupp]

    MINDBODY (NASDAQ:MB) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued on Monday.

Best Tech Stocks To Buy For 2019: CommVault Systems, Inc.(CVLT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Victory Capital Management Inc. lowered its stake in CommVault Systems, Inc. (NASDAQ:CVLT) by 43.6% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 465,638 shares of the software maker’s stock after selling 359,373 shares during the period. Victory Capital Management Inc.’s holdings in CommVault Systems were worth $30,662,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    CommVault Systems, Inc. (NASDAQ:CVLT) has been assigned an average rating of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.57.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    CommVault Systems, Inc. (NASDAQ:CVLT) VP Brian Carolan sold 5,484 shares of the stock in a transaction that occurred on Wednesday, June 13th. The stock was sold at an average price of $71.90, for a total transaction of $394,299.60. Following the completion of the sale, the vice president now owns 102,796 shares in the company, valued at $7,391,032.40. The transaction was disclosed in a filing with the SEC, which is available through this link.

  • [By ]

    In addition, Elliott Management, which often pushes for M&A and other strategic transactions at targeted companies, made investments in EQT Corp. (EQT) , CommVault Systems Inc. (CVLT) , Sabre Corp. (SABR) , Teradyne Inc. (TER)  and Windstream Holdings Inc. (WIN)

Leave a Reply

Your email address will not be published. Required fields are marked *